Skip to main content

This job has expired

You will need to login before you can apply for a job.

Head of Development, Ex Vivo Programs

Employer
Intellia Therapeutics
Location
Cambridge, MA
Start date
Feb 23, 2024

View more

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

How you will Achieve More with Intellia:

We are hiring a Head of Development for Ex VivoPrograms tooverseeall functions fortheex vivoprograms, including clinical, regulatory,and biometrics. You will act as a Program Team Lead for an innovative new Ex Vivo Cell Therapy Program.

Youwillbe responsible for the development and execution of short and long-term medical plans supportingex vivocell therapy programsin both immuno-oncology andautoimmunity andaligning them with overall business goals.A significant portion of time will beexternally facingand theHead of Development Ex Vivowill provide therapeutic area/product expertise inoncological and autoimmune indicationsand understand both the patient’s and physician’s point of view. Working with cross-functional colleagues, you will ensure thatthe clinical development plan is in line with the brand strategies and helps support successful product development, medical launch, and commercialization.

Program Team Leader, Ex Vivo Cell Therapy Program

  • Accountable for the achievement of program milestones in scope, time, budget together with sub-team leads and functional leads that is aligned with corporate strategy.
  • Ensures cross-functional plans are supporting the overall program strategy.
  • Lead and work closely with the Program Manager to provide strategic, process, and operational leadership for the successful delivery of program goals and life-cycle management activities.
  • Fosters high performing team culture and cross-functional collaboration.
  • Proactively responds to the dynamics of a changing competitive environment and challenges, facilitates adjustments in functional plans in response to changes in strategic direction.
  • Ensures appropriate resourcing, support, and input from functions and coordinates with Functional Heads to align with business and program imperatives.
  • Provide strategic and tactical leadership and support to sub-team leaders to set the vision and direction for the program(s) and execute on key deliverables.
  • Reports on progress of program, plans, changes, critical path(s), issues and risk resolution and impact to the Executive Leadership Team.
  • Support activities related to safety evaluations and reporting requirements.

Head Development, Ex Vivo Programs

  • Lead and oversee early and late-stage clinical development plans and execution of theex vivoprograms, including medical and registrational strategies and tactics for assigned clinical research projects.
  • Head up the development team starting at the time of CTA/INDor proof of concept depending on the program, including all functions: clinical, regulatory, biostatistics, program management, clinical operations, tech ops/CMC, clinical pharmacology, research, and preclinical development, to design and execute clinical development plans for assigned projects.
  • Provide clinical leadership in preparation of clinical protocols, regulatory documents, and regulatory agency interactions, including an active presence in internal governance and review committees.
  • Play a key role in the development of analysis plans, and in the review, interpretation and communication of clinical trial data, safety, and efficacy trials.
  • Establish strong external networks of thought leaders in collaboration with members in medical, medical affairs, and Research and Early Development to support clinical development strategies and help optimize program plans and protocols.
  • Ensure high-quality clinical trials that meet key milestones, maintain timelines, and ensure ongoing medical monitoring and oversight of clinical trial data and external data collection.
  • Provide strategic perspective and guidance to Research and Early Development on decisions that may have significant clinical components and implications.
  • Collaborate closely with non-clinical, Regulatory Affairs, Clinical Operations, CMC, and Biometrics to ensure tight strategic integration of development plans and strategies.
  • Provide leadership, coaching, and mentorship to the clinical development team members and ensure their deliverables on key program and study metrics are met.

About You:

We are looking for candidates with a Doctoral degree (M.D) or foreign equivalent. We will consider a Ph.D.with 12yearsor moreexperiencein drug development roles in a pharmaceutical industrial R&D setting. Additional role requirements include:

  • Served as clinical and, ideally, strategic enterprise leader who has delivered in multiple phases of drug development (including clinical protocol development)and ability to deliver against challenging goals.
  • Participated in key regulatory interactions with the FDA, EMA, or similar national agencies.
  • Knowledge and experience in gene therapyand/or oncology and autoimmunityis preferred.
  • Strong analytical and problem-solving skills.
  • Excellent communicator: able to motivate others from a position of influence, negotiate conflict situations and forge consensus.
  • Professional demeanor & strong stakeholder relationship skills when dealing with external customers (KOLs/regulatory bodies), internal colleagues, and Executive Leadership Team.
  • Demonstrated successful ability to lead and manage complex developmental program teams in a cross-functional environment.

Meet your future team:

The Program Leadership Team at Intellia is made up of one or more people in functions related to clinical research, including but not limited to biometrics, clinical operations, clinical pharmacology, medical science, project management and regulatory affairs. We are here because we believe genome editing has incredible potential to treat and cure life-threatening and fatal diseases, and we believethat Intelliahas the rightpeople, strategy and culture to do it well.

The team is led by our CMO, a physician and medical oncologist with over 25 years of experience in large pharma and biotech drug development. Other senior team members have 10 or more years of similar experience, including many with prior direct experience in nucleic acid therapeutics and cell therapy. Your medical colleagues at Intellia are physicians/scientists who share responsibility across Intellia's three development-stage programs as Project Leads and Medical Leads. Their responsibility will increase in the coming years as Intellia’s pipeline moves further into clinical development.

#LI-KO2

Covid-19 Vaccination Policy:All Intellia employees, regardless of work location, are expected to follow all applicable federal, state, and local public health regulations and guidelines, and are strongly encouraged to follow all public health recommendations, including being vaccinated for COVID-19.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert